Filing Details
- Accession Number:
- 0000014272-22-000170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-15 19:29:45
- Reporting Period:
- 2022-09-13
- Accepted Time:
- 2022-09-15 19:29:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1451604 | V David Elkins | 430 E. 29Th Street 14Th Floor New York NY 10016 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2022-09-13 | 30,000 | $71.35 | 100,460 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2022-09-13 | 2,063 | $48.49 | 102,523 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2022-09-13 | 121,214 | $48.49 | 223,737 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2022-09-13 | 103,951 | $71.29 | 119,786 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2022-09-13 | 2,063 | $0.00 | 2,063 | $48.49 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2022-09-13 | 121,214 | $0.00 | 121,214 | $48.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-08-01 | No | 4 | M | Direct | |
| 0 | 2028-08-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 204 | Indirect | BMS Savings and Investment Program |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.350 to $71.380, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Shares acquired from options exercised in a net exercise and hold transaction with broker.
- 103,951 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.240 to $71.405, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- All of the shares are currently exercisable.
Billionaire Hedge Funds
